MYC and sebaceous adenocarcinoma: For this reason, high-MYC-expressing neoplastic cells, including three recently established primary sebaceous carcinoma cell lines, have demonstrated sensitivity to glutamine analogs following the selective suppression of the metabolic reactions that utilize glutamine [5,52].